- Report
- August 2025
- 182 Pages
Global
From €3134EUR$3,545USD£2,706GBP
€3483EUR$3,939USD£3,007GBP
- Report
- June 2025
- 233 Pages
Global
From €2210EUR$2,500USD£1,908GBP
- Report
- July 2025
- 175 Pages
Global
From €3970EUR$4,490USD£3,427GBP
- Report
- March 2025
- 290 Pages
Global
From €3970EUR$4,490USD£3,427GBP
- Report
- August 2025
- 386 Pages
Global
From €5172EUR$5,850USD£4,465GBP
- Report
- February 2025
- 200 Pages
Global
From €3970EUR$4,490USD£3,427GBP
- Report
- February 2025
- 181 Pages
Global
From €3979EUR$4,500USD£3,435GBP
- Report
- January 2025
- 144 Pages
Global
From €2794EUR$3,160USD£2,412GBP
€3492EUR$3,950USD£3,015GBP
- Report
- August 2024
- 164 Pages
Global
From €4416EUR$4,995USD£3,813GBP
- Report
- May 2021
- 177 Pages
United States
€1322EUR$1,495USD£1,141GBP
- Report
- February 2023
- 152 Pages
Global
From €2210EUR$2,500USD£1,908GBP
- Report
- January 2024
- 150 Pages
Global
From €3404EUR$3,850USD£2,939GBP
€4288EUR$4,850USD£3,702GBP
- Report
- October 2022
- 119 Pages
Global
From €3979EUR$4,500USD£3,435GBP
- Report
- February 2023
- 198 Pages
Global
From €6631EUR$7,500USD£5,725GBP
- Report
- January 2024
- 200 Pages
Global
From €3669EUR$4,150USD£3,168GBP
- Report
- October 2023
- 145 Pages
Global
From €2785EUR$3,150USD£2,404GBP
- Report
- June 2024
- 200 Pages
Global
From €7029EUR$7,950USD£6,068GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4377EUR$4,950USD£3,778GBP
- Report
- February 2023
- 99 Pages
Global
From €3492EUR$3,950USD£3,015GBP
- Report
- February 2024
- 120 Pages
Global
From €4200EUR$4,750USD£3,626GBP

The Insomnia Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Insomnia drugs are used to treat difficulty sleeping, and can be divided into two categories: sedative-hypnotics and non-sedative hypnotics. Sedative-hypnotics are drugs that act on the central nervous system to induce sleep, while non-sedative hypnotics are drugs that act on the brain to improve sleep quality without causing sedation. Commonly prescribed insomnia drugs include benzodiazepines, non-benzodiazepines, and melatonin receptor agonists.
Some companies in the Insomnia Drug market include Sanofi, Pfizer, Merck, GlaxoSmithKline, and Takeda. Show Less Read more